Collectively, this work reveals new insights into the molecular mechanisms driving CTC cluster formation and highlights PAK2 as a potential prognostic biomarker and therapeutic target for preventing metastasis in patients with breast cancer. Here, PAK2 is linked to breast carcinoma.